facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause

Insights


Lump-Sum Investing vs Dollar-Cost Averaging - Round 2: Actual Outcomes

In a recent piece, we explored how to invest available cash: Should you invest it all right away as a lump sum? Or are you better off wading in more gradually with dollar-cost averaging? In round one, we discussed why lump-sum investing is generally expected to generate the highest returns over time. That said, general rules don't always apply to you. Let’s look at when dollar-cost averaging may be preferred after all.

Read More

2020 Steady as She Goes

Third Quarter 2020|Jim Williams| Looking back at the year 2020, and forward to year end, we can be sure that this is one for the history books. By almost any measure, 2020 has been a year to test one's resolve as an investor. In times of market turmoil, investor resolve is clearly the difference between success and failure.

Read More

Value Premium

Second Quarter 2020|Jim Williams| When we establish the investment policies we use to drive decisions about the investment portfolios we manage, we include in those conversations a discussion of premiums; most notably, the equity premium, the value premium, the size premium, and the profitability premium.

Read More

Coronavirus Edition (what else?)

First Quarter 2020|Jim Williams| The last few months have presented a rapidly changing financial landscape for those in the investment management, financial planning, tax return preparation and tax advice world. In a series of fits and starts, a number of changes took place. Needless to say, these abrupt changes have created a good bit of thrashing.

Read More

You, Your Investments, and the Coronavirus

The term “novel coronavirus” is named after its crown-shaped particles, and it has quickly grabbed global headlines. As the viral news has spread, so too has financial uncertainty. What’s going to happen next? Will it infect our economy? So far, U.S. markets have remained relatively immune. But should you try to dodge markets that have been exposed?

Read More